4
Changes in Ownership
Transcode Therapeutics, Inc. Filed Acc 0001104659-23-073872
Chief Executive Officer bought 18,607 shares at an average $2.62 ($48,665)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dudley Robert Michael Chief Executive Officer | 2023-06-20 | Purchase | +6,607 | $2.55 | $16,847 | 70,262 | D |
| Dudley Robert Michael Chief Executive Officer | 2023-06-21 | Purchase | +12,000 | $2.65 | $31,818 | 82,262 | D |
| Open-market purchases · 18,607 sh · avg $2.62 · $48,665 | |||||||
Loading xslF345X04/tm2319496-1_4seq1.xml…